In biotechnology, every discovery carries a duty.
Biotech leader 'n investor building innovation with faith, discipline,
#MAHA 🇺🇸 Constitution| AmericaFirst
Advocate for women in science: My journey in biotechnology has taught me one thing: knowledge is only powerful when paired with responsibility.
Hi, I’m Ehrie, here, I’ll share lessons from science, leadership, resilience to help future leaders navigate complexity with clarity.
Biotech teams don’t need “faster.” They need smarter loops.
Here’s my 5-point Agile for Biotech cheat sheet 👇
1️⃣ Hypothesize → test.
2️⃣ Short sprints
3️⃣ Pair science + ops early.
4️⃣ Data = demo
5️⃣ One weekly reflection
Goal: clarity in motion.
#Biotech#Leadership#Agile
@MCollinsUS Regardless of philosophy, ERs treat everyone. When preventive care fails, costs rise for all of us. Smart policy is the one that reduces avoidable illness and uses resources transparently and efficiently.
@RapidResponse47 I feel the difference when cops and feds surge. Kids play outside, sirens fade. More of this, less politics. Thank you to the agents and local partners. #SafeStreets
@elonmusk Same here. In blue cities, results > rhetoric: crack down on repeat offenders, expand school choice, cut red tape for small biz. When safety and opportunity rise, politics follows.
@zenhoneycutt Accountability is essential. When safety concerns arise, thorough, unbiased investigation is the best way to protect both science and public confidence.
If these numbers are accurate, that’s a systemic issue worth transparent investigation. Accountability in federal health programs protects both patients and practitioners.
🚨 The U.S. sent $2.7 TRILLION in Medicare & Medicaid funds overseas to ineligible recipients. THAT'S 8% OF OUR NATIONAL DEBT!
Do you support Kash Patel to investigate this?
Yes or No?
@TheWarMonitor The 2A says “the right of the people,” not “citizens.” Founding militias included immigrants, the test was allegiance and good character, not passports. Punish criminals, not blanket bans.
@SebGorka@BarackObama@JoeBiden I want every hostage home. But after pallets of cash and “quiet” diplomacy, appeasement failed. Cut off Tehran and back Israel to dismantle Hamas, so no family lives this nightmare again.
We don’t need less innovation, we need more responsible translation. The future of biotech will be built by those who treat ethics as a design principle, not an afterthought.
How do you define responsible science?
Everyone loves talking about biotech breakthroughs.
Fewer talk about bioethics, the invisible framework that decides what we should do, not just what we can.
Here’s a quick decode for non-scientists 🧵
#Bioethics#Biotech#Leadership#WomenInSTEM#ScienceCommunication
5️⃣ My take:
Biotech’s power is only as trustworthy as the ethics guiding it.
And that trust is what will define the next decade of scientific leadership.
4️⃣ Ethics can scale like innovation.
The same way we scale R&D pipelines, we can scale ethical thinking:
Pre-review ethics boards in startups
Transparent AI models
“What-if” sessions before clinical trials
3️⃣ Who decides what’s “responsible”?
Scientists bring technical truth.
Policymakers bring frameworks.
Society brings values.
The best decisions happen when those three perspectives meet early, not after the experiment is done.
2️⃣ The real challenge isn’t science, it’s translation.
We can design molecules faster than we can decide how they’ll be used.
Ethics is the bridge between research ambition and human consequence.
1️⃣ Ethics isn’t a brake pedal, it’s a steering wheel.
It doesn’t slow innovation; it directs it.
Every major biotech advance from gene editing to AI-driven trials, carries both potential and responsibility.
@HHSGov I’m proud to see our nation’s health agencies staying the course. Even during challenges, we stand united in protecting lives, advancing science, and upholding the values that define American resilience.
We’re reassured to see the FDA holding the line on its core safety functions. The biomedical community understands how delicate the balance is between continuous oversight and the systems that protect patients every day.
All FDA activities related to imminent threats to the safety of human life or protection of property will continue. This includes detecting and responding to public health emergencies and continuing to address existing critical public health challenges by managing recalls, mitigating drug shortages, and responding to outbreaks related to foodborne illness and infectious diseases. It also includes surveillance of adverse event reports for issues that could cause human harm, the review of import entries to determine potential risks to human health, conducting for cause and certain surveillance inspections of regulated facilities, and related regulatory testing activities, and criminal enforcement work and certain civil investigations.
https://t.co/MuWk9q304k
@tony_gueli@timburchett I want affordability too, but supply + jobs beat slogans. GOP path: rezone for more housing, faster permits, lower biz taxes, and enforce public safety so employers stay.